Home›Research›Compare›Angiotensin (1-7) vs SS-31
Peptide ComparisonAngiotensin (1-7) vs SS-31
Both are Longevity & Cellular peptides.
Angiotensin (1-7)
Ang-(1-7)
Half-life: ~9–10 sec (rat)
No providers listed yet
SS-31
Elamipretide
Half-life: ~2-3 hours
50 providers listed
SS-31 carries stronger published evidence (RCT, 11 key studies) than Angiotensin (1-7) (RCT, 15); both are research compounds.
Angiotensin (1-7)
Evidence
Half-life
~9–10 sec (rat)
SS-31
Evidence
Half-life
~2-3 hours
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | SS-31 |
| Less frequent dosing (longer half-life) | Angiotensin (1-7) |
| More provider options (0 vs 50) | SS-31 |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
Angiotensin (1-7)
SS-31
Angiotensin (1-7)
The Effect of Angiotensin (1-7) on Serum Metabolomics in Obese Type 2 Diabetic Mice.
Perioperative Angiotensin-(1-7) for Postoperative Cognitive Vulnerability Following Coronary Artery Bypass Su…
Severe Acute Hypertension Causes Hemolysis With Release of PEP and ACE Inhibitor.
Neuroprotective effects of telmisartan in a harmaline-induced model of essential tremor: modulation of the re…
+11 more
SS-31
Protective Effect of Mitochondria-Targeted Polydopamine Nanoparticles in Alleviating Hepatic Ischemia-Reperfu…
Effect of mitochondrial dysfunction on scar formation after spinal cord injury.
Elamipretide (SS-31) promotes recovery by preserving mitochondrial bioenergetics and neural remodeling after…
Targeting Mitochondrial Dysfunction With Elamipretide (SS-31) Improves Skeletal Muscle Performance in a HFpEF…
+7 more
About Angiotensin (1-7)
Binds Mas receptor (MasR), activating nitric oxide synthase and reducing oxidative stress. Opposes TGF-β and angiotensin II signaling to reduce fibrosis. Enhances insulin sensitivity and provides cardiovascular protection.
About SS-31
Targets cardiolipin in inner mitochondrial membrane; stabilizes cristae structure; enhances electron transport chain efficiency; reduces mitochondrial ROS
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
Angiotensin (1-7)
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
SS-31
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Angiotensin (1-7)
Not enough vendor pricing yet.
SS-31
Where to source these peptides
Angiotensin (1-7)
Browse directory →
Providers offeringSS-31
50 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Longevity & Cellular Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated July 22, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). Angiotensin (1-7) vs SS-31 — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/angiotensin-1-7/ss-31